{"id":1011680,"date":"2026-10-20T08:25:16","date_gmt":"2026-10-20T12:25:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/"},"modified":"2026-10-20T08:25:16","modified_gmt":"2026-10-20T12:25:16","slug":"ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/","title":{"rendered":"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026"},"content":{"rendered":"<h2>\n\u00a0Conference call scheduled for 4:30 p.m. Eastern Time<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>WALTHAM, Mass., Oct.  20, 2026  (GLOBE NEWSWIRE) &#8212; Ardelyx Inc. (Nasdaq: ARDX), (\u201cArdelyx\u201d or the \u201cCompany\u201d) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the third quarter of 2026.<\/p>\n<p>\n        <strong>Webcast Information<\/strong><br \/>\n        <br \/>A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BQoQbSzs5Gp_2_Zv4lqWLPwkkAj0OIUyL9K7NcndkM12TzMvYMNcuJ-xeSMijv268I-iCJ0yf0KrozVAcHro8GRMdpe3GiXBWFFR3p_BT9E=\" rel=\"nofollow\" target=\"_blank\">www.ardelyx.com<\/a>.<\/p>\n<p>An archived replay of the webcast and related presentation materials will be available on the Company\u2019s website following the event.<\/p>\n<p>\n        <strong>Conference Call Details<\/strong><br \/>\n        <br \/>Domestic (toll-free): 877-346-6112<br \/>International (toll): +1 848-280-6350<\/p>\n<p>\n        <strong>About Ardelyx<br \/><\/strong>Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA\u00ae (tenapanor) and XPHOZAH\u00ae (tenapanor). The company\u2019s pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation (CIC) and RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx works with partners to develop and commercialize its products outside of the United States. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SDuWBM3NOlxCuml876CujI_cHBp_QGip615O6t0T0ZUx2dSyvpdw-y-0mjw5e60yKkSGlRS4uewr9C8341e3108qnVJSdF1veZhzDDfoAcwxBxTyBIGUFxLxpV8msCSUGRryGSwLq6INAd7pga_E2zgUMGODFQE8jiM8r1T3e1KaAJKVhHF3JKeOjqEESzr3KpJNDgrAgzXlg8bsIE7gNUdNPhUfmUxgiULcDgksglgNixtOaWZ8iBWozc0KGayKczD4vmqnHH4UeOACmNVJ-w==\" rel=\"nofollow\" target=\"_blank\">https:\/\/ardelyx.com\/<\/a> and connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o5v8-Jb-yNXhwI6xLC7Nr1oOFxcbVL9qKyiRo7YOZR2axRHq-Jafw4v4s3AeMgjjYB9ReFxquylpa1pP0RpZVZrsrKKUgnzK01KklSfhXbazkyNhvumMAE470JhEpC5ecc_acR5FUDIgCQJBEM3XYD_Bu6zBTg5xsz-Fu4HQmj1iSaT5sNSfBlD8NysukcWa0IP0GlzmiRuH_CRMh2sgCSgOB06UHyTQYIhkKvwR67lF87WI91H1t03gnvM-1Kw6dL7nUuzkFLYLIZ3EaszBazGRdxoCAhw20d_JNG_OuNsgB0WtRC25aOlF4ZNxMDOj\" rel=\"nofollow\" target=\"_blank\">X (formerly known as Twitter)<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A5Kl6d9gpoEY0BQInjlPT3Y5Jl0_8ydAsFTI-oFvfUrVWraPdUR0Egp8mXV9qeD2L_e17GCZ9zeCwJE3VIKloab3dheBqE9S5Adccw9TvBYqEP4DebOm_m5Upx81pX09KgdVsxFpdPYpckVhsjh1U0IochKjYVvCMvkMhqMbabKS7jJG72y69FzYwTtVfvQPaIWfpIIRru0CRNYoq02bEAv6PqH-sPCdTTMT66mhWJsTNUVkd9NZpHxVDcV8lMoF\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_-80kvKlye51sKqRjP41P_M4jHyEKTq7aJ2QRLjsWX4VyW3O05saJ2Aq-A1ulcdYxb7VarTPvTxh7gKsjnj3Q-EmLNju9jCem8zszttCKJCxkQ3SqD__iZySftGAIRWMQ-dsf0C43oibgpBSkUN2Hs3v8JfQhnrzQJ1vctAM2i_1cqvywp2dGiTNLeeh1Bs1DI6Tl5npSMHuRkpDaWqlVpYyhQ0jrLlmpCMrQr-703ZFbJAYGwk9pu3Rsb-cfiFI\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Lisa Caperelli<br \/>SVP, Investor Relations &amp; Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=upQlq2vM6LOW5wbR1PD2K4EcLwCzGKpa2aH_9cZMvDf7d2RtZfWX5DSgFE141jncbQXLzY6eB79VPMEKfznLGH0l2dlsiNEPfnbYuoE3M2k=\" rel=\"nofollow\" target=\"_blank\">lcaperelli@ardelyx.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Lindsey Manuel<br \/>Associate Director, Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-CoGts9wkvwqb53v-2xcRxbMzz__rx32jGPBqGYLy8PklkgsAynO_lVJiBy_cvM9jgSeYy7fGw0-aT_FlsWMpdHvKJO8BApmJuEIfVyaaig=\" rel=\"nofollow\" target=\"_blank\">lmanuel@ardelyx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjZmMmNjNTktOTE0Mi00NDE3LWI2ZmMtNjJjZTg5ZWU3Y2U0LTEwMTY5ODEtMjAyNi0xMC0yMC1lbg==\/tiny\/Ardelyx-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) &#8212; Ardelyx Inc. (Nasdaq: ARDX), (\u201cArdelyx\u201d or the \u201cCompany\u201d) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the third quarter of 2026. Webcast Information A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at www.ardelyx.com. An archived replay of the webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1011680","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"\u00a0Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) &#8212; Ardelyx Inc. (Nasdaq: ARDX), (\u201cArdelyx\u201d or the \u201cCompany\u201d) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the third quarter of 2026. Webcast Information A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at www.ardelyx.com. An archived replay of the webcast &hellip; Continue reading &quot;Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-20T12:25:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026\",\"datePublished\":\"2026-10-20T12:25:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/\",\"name\":\"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=\",\"datePublished\":\"2026-10-20T12:25:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/","og_locale":"en_US","og_type":"article","og_title":"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Market Newsdesk","og_description":"\u00a0Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) &#8212; Ardelyx Inc. (Nasdaq: ARDX), (\u201cArdelyx\u201d or the \u201cCompany\u201d) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Tuesday, November 3, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the third quarter of 2026. Webcast Information A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at www.ardelyx.com. An archived replay of the webcast &hellip; Continue reading \"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-20T12:25:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026","datePublished":"2026-10-20T12:25:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/","name":"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=","datePublished":"2026-10-20T12:25:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0ODc2OSM3OTA0MTc0IzIwMDU0MDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-third-quarter-2026-financial-results-on-november-3-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1011680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1011680"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1011680\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1011680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1011680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1011680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}